BG Medicine Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
BG Medicine (BGMD) Reports Q3 Loss of $0.27/Share
November 17, 2015 7:52 AM ESTBG Medicine (: BGMD) reported Q3 EPS of ($0.27), versus ($0.28) reported last year. Revenue for the quarter came in at $334 million, versus $695 million reported last year.
Our operating results in the third quarter of 2015 reflect our ongoing efforts to extend our cash runway through the... More



